Luspatercept
ATC B03XA06 · 10 markets · 20 records
US 2 records · 2 strengths
CA 2 records · 2 strengths
AU 2 records · 2 strengths
- 75 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial
- 25 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial
SG 2 records · 2 strengths
- 75 mg/vialinjectionREBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL
- 25 mg/vialinjectionREBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL
ES 2 records · 2 strengths
TW 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 strengths
- 75 mginjectionREBLOZYL 25 mg, poudre pour solution injectable
- 25 mginjectionREBLOZYL 25 mg, poudre pour solution injectable
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.